288 related articles for article (PubMed ID: 28560782)
21. Bone marrow-derived mesenchymal stromal cell treatment in patients with ischaemic heart failure: final 4-year follow-up of the MSC-HF trial.
Mathiasen AB; Qayyum AA; Jørgensen E; Helqvist S; Kofoed KF; Haack-Sørensen M; Ekblond A; Kastrup J
Eur J Heart Fail; 2020 May; 22(5):884-892. PubMed ID: 31863561
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous intramyocardial delivery of mesenchymal stem cells induces superior improvement in regional left ventricular function compared with bone marrow mononuclear cells in porcine myocardial infarcted heart.
Tao B; Cui M; Wang C; Ma S; Wu F; Yi F; Qin X; Liu J; Wang H; Wang Z; Ma X; Tian J; Chen Y; Wang J; Cao F
Theranostics; 2015; 5(2):196-205. PubMed ID: 25553108
[TBL] [Abstract][Full Text] [Related]
23. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
[TBL] [Abstract][Full Text] [Related]
24. Differential change in left ventricular mass and regional wall thickness after cardiac resynchronization therapy for heart failure.
Zhang Q; Fung JW; Auricchio A; Chan JY; Kum LC; Wu LW; Yu CM
Eur Heart J; 2006 Jun; 27(12):1423-30. PubMed ID: 16682380
[TBL] [Abstract][Full Text] [Related]
25. Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction.
Udelson JE; Feldman AM; Greenberg B; Pitt B; Mukherjee R; Solomon HA; Konstam MA
Circ Heart Fail; 2010 May; 3(3):347-53. PubMed ID: 20299607
[TBL] [Abstract][Full Text] [Related]
26. Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trial.
Premchand RK; Sharma K; Mittal S; Monteiro R; Dixit S; Libbus I; DiCarlo LA; Ardell JL; Rector TS; Amurthur B; KenKnight BH; Anand IS
J Card Fail; 2014 Nov; 20(11):808-16. PubMed ID: 25187002
[TBL] [Abstract][Full Text] [Related]
27. Less invasive ventricular reconstruction for ischaemic heart failure.
Klein P; Anker SD; Wechsler A; Skalsky I; Neuzil P; Annest LS; Bifi M; McDonagh T; Frerker C; Schmidt T; Sievert H; Demaria AN; Kelle S
Eur J Heart Fail; 2019 Dec; 21(12):1638-1650. PubMed ID: 31797492
[TBL] [Abstract][Full Text] [Related]
28. The reverse remodeling effect of mesenchymal stem cells is independent from the site of epimyocardial cell transplantation.
Arsalan M; Dhein S; Aupperle H; Rastan AJ; Barten MJ; Walther T; Mohr FW; Garbade J
Innovations (Phila); 2013; 8(6):433-9. PubMed ID: 24225815
[TBL] [Abstract][Full Text] [Related]
29. Left ventricular geometry as a major determinant of left ventricular ejection fraction: physiological considerations and clinical implications.
Triposkiadis F; Giamouzis G; Boudoulas KD; Karagiannis G; Skoularigis J; Boudoulas H; Parissis J
Eur J Heart Fail; 2018 Mar; 20(3):436-444. PubMed ID: 29105899
[TBL] [Abstract][Full Text] [Related]
30. Cardiac function response to stenting in atherosclerotic renal artery disease with and without heart failure: results from the Carmel study.
Kawarada O; Kume T; Zen K; Nakamura S; Hozawa K; Akimitsu T; Asano H; Ando H; Yamamoto Y; Yamashita T; Shinozaki N; Odashiro K; Sato T; Yuba K; Sakanoue Y; Uzu T; Okada K; Fitzgerald PJ; Honda Y; Yasuda S
ESC Heart Fail; 2019 Apr; 6(2):319-327. PubMed ID: 30614643
[TBL] [Abstract][Full Text] [Related]
31. Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure.
Kasama S; Toyama T; Hatori T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
Heart; 2006 Oct; 92(10):1434-40. PubMed ID: 16621879
[TBL] [Abstract][Full Text] [Related]
32. Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction.
Udelson JE; McGrew FA; Flores E; Ibrahim H; Katz S; Koshkarian G; O'Brien T; Kronenberg MW; Zimmer C; Orlandi C; Konstam MA
J Am Coll Cardiol; 2007 Jun; 49(22):2151-9. PubMed ID: 17543634
[TBL] [Abstract][Full Text] [Related]
33. [Efficacy and safety of long-term application of spironolactone in patients with moderate and severe chronic heart failure receiving optimal therapy].
Skvortsov AA; Mareev VY; Chelmakina SM; Baklanova NA; Belenkov IuN
Kardiologiia; 2007; 47(10):12-23. PubMed ID: 18260939
[TBL] [Abstract][Full Text] [Related]
34. Comparison of left ventricular reverse remodeling induced by cardiac contractility modulation and cardiac resynchronization therapy in heart failure patients with different QRS durations.
Zhang Q; Chan YS; Liang YJ; Fang F; Lam YY; Chan CP; Lee AP; Chan KC; Wu EB; Yu CM
Int J Cardiol; 2013 Aug; 167(3):889-93. PubMed ID: 22330007
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of bone marrow mononuclear cells delivered through a graft vessel for patients with previous myocardial infarction and chronic heart failure: an echocardiographic study of left ventricular remodeling.
Duan F; Qi Z; Liu S; Lu X; Wang H; Gao Y; Wang J
Med Ultrason; 2015 Jun; 17(2):160-6. PubMed ID: 26052565
[TBL] [Abstract][Full Text] [Related]
36. Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trial.
Hulot JS; Salem JE; Redheuil A; Collet JP; Varnous S; Jourdain P; Logeart D; Gandjbakhch E; Bernard C; Hatem SN; Isnard R; Cluzel P; Le Feuvre C; Leprince P; Hammoudi N; Lemoine FM; Klatzmann D; Vicaut E; Komajda M; Montalescot G; Lompré AM; Hajjar RJ;
Eur J Heart Fail; 2017 Nov; 19(11):1534-1541. PubMed ID: 28393439
[TBL] [Abstract][Full Text] [Related]
37. Left Ventricular Reverse Remodeling With Biventricular Versus Right Ventricular Pacing in Patients With Atrioventricular Block and Heart Failure in the BLOCK HF Trial.
St John Sutton M; Plappert T; Adamson PB; Li P; Christman SA; Chung ES; Curtis AB
Circ Heart Fail; 2015 May; 8(3):510-8. PubMed ID: 25697851
[TBL] [Abstract][Full Text] [Related]
38. Adrenergic receptor gene polymorphism and left ventricular reverse remodelling after cardiac resynchronization therapy: preliminary results.
Pezzali N; Curnis A; Specchia C; Carubelli V; Covolo L; Donato F; Auricchio A; Regoli F; Metra M
Europace; 2013 Oct; 15(10):1475-81. PubMed ID: 23729404
[TBL] [Abstract][Full Text] [Related]
39. Left ventricular remodelling and prognosis after discharge in new-onset acute heart failure with reduced ejection fraction.
van den Berge JC; Vroegindewey MM; Veenis JF; Brugts JJ; Caliskan K; Manintveld OC; Akkerhuis KM; Boersma E; Deckers JW; Constantinescu AA
ESC Heart Fail; 2021 Aug; 8(4):2679-2689. PubMed ID: 33934556
[TBL] [Abstract][Full Text] [Related]
40. Endomyocardial implantation of autologous bone marrow mononuclear cells in advanced ischemic heart failure: a randomized placebo-controlled trial (END-HF).
Santoso T; Siu CW; Irawan C; Chan WS; Alwi I; Yiu KH; Aziz A; Kwong YL; Tse HF
J Cardiovasc Transl Res; 2014 Aug; 7(6):545-52. PubMed ID: 25079593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
